Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRELI domain containing 2 pseudogene 1 (PRELID2P1) is a human pseudogene, meaning it is a genomic sequence similar to a functional gene but typically considered non-coding and non-functional. There is no evidence that PRELID2P1 encodes a protein or functions as a direct drug target or biomarker. Like other pseudogenes, it could potentially play a regulatory role in gene expression (e.g., via piRNA or RNA interference pathways) but no specific data exists for PRELID2P1 itself. It is not classified as a receptor, enzyme, transporter, or other classic therapeutic target. PRELID2P1 is designated as a pseudogene, not a protein-coding gene or functional receptor. While pseudogenes can sometimes regulate gene expression through mechanisms involving small RNAs (such as piRNAs), there is no direct evidence linking PRELID2P1 to specific biological pathways or diseases. No drugs, mechanisms of action, or safety concerns are associated with this pseudogene as it is not a therapeutic target. Databases such as GeneCards and BioGPS acknowledge PRELID2P1 but only as a pseudogene without further functional annotation. Its function, if any, is limited to non-coding RNA regulation as postulated for pseudogenes in general. No aliases or alternative names are documented in major databases. No clinical roles, diagnostic or prognostic biomarkers, or direct links to pharmacology exist for this gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRELI domain containing 2 pseudogene 1 (PRELID2P1).